C. R. Bard clinical trials
Acquired by Becton, Dickinson and Company, Dec 29, 2017 · source ↗
The registry lists 117 studies whose lead sponsor is C. R. Bard. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Before and after it joined Becton, Dickinson and Company
- First submitted before C. R. Bard became part of Becton, Dickinson and Company
- 91
- First submitted after C. R. Bard became part of Becton, Dickinson and Company
- 26
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- C. R. Bard117 studies
Something wrong with this grouping? Tell us on the Becton, Dickinson and Company page.
Studies
Recruiting first, then most recently updated. Showing 50 of 117. List all 117 → · All Becton, Dickinson and Company studies →
- Evaluation of Male and Female External Catheters for Urine Output Monitoring in the ICUEnrolling by invitationNCT07744945
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant AugmentationRecruitingNCT05945329Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF SystemRecruitingNCT04634916Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung ResectionNot yet recruitingNCT06934486
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal HypertensionRecruitingNCT06669806Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)RecruitingNCT07016698Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- This Study Will Collect Clinical and Patient Reported Satisfaction Data From Males Requiring Urine Output Management Overnight in the Home Setting.CompletedNCT06850259Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Prophylactic Reinforcement of Ventral Abdominal Incisions TrialActive, not recruitingNCT03911700Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- The BD Liverty™ TIPS Stent Graft StudyActive, not recruitingNCT05711316Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- An Evaluation of the PureWick™ Male External Catheter Versus an Established Comparator Overnight in the Home Setting for Incontinence in Adult MalesCompletedNCT07282860Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous FistulaeActive, not recruitingNCT03506308Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Venclose digiRF System Post Market StudyActive, not recruitingNCT05504070Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal ArteriesCompletedNCT05556681Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent GraftCompletedNCT04261686Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- everlinQ endoAVF Post Market StudyTerminatedNCT02682420Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- everlinQ Endovascular Access Systems Enhancements (EASE-2) StudyCompletedNCT03708562Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural CatheterCompletedNCT02649894Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Test for Pre Operative Skin PreparationsCompletedNCT00799812Phase 3
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Topical Antimicrobial Effectiveness TestingCompletedNCT01366417Phase 4
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Topical Antimicrobial Effectiveness TestingCompletedNCT01314703Phase 4
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- everlinQ Endovascular Access System Enhancements (EASE) StudyCompletedNCT03708770Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Evaluating Safety and Effectiveness of Octenidine DihydrochlorideCompletedNCT03140254Phase 2
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Components of Chlorhexidine Gluconate DressingCompletedNCT01112020Phase 1
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Preoperative Skin Preparation EvaluationCompletedNCT00636480Phase 3
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 AntisepticsCompletedNCT00692484Phase 3
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural EffusionsCompletedNCT02227732Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)CompletedNCT02119832Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001CompletedNCT02119845Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Novel Endovascular Access Trial (NEAT)CompletedNCT02036671Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- PureWick™ Adolescent StudyCompletedNCT06631313Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.CompletedNCT06666426Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- PureWick™ France and U.S. At-Home Pilot StudyCompletedNCT05710718Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market InvestigationTerminatedNCT04626427Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Male External Catheters' Comparison of Comfort and EfficacyCompletedNCT05955560Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- The Pristine Post-Market StudyTerminatedNCT05228132Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA BalloonCompletedNCT03193619
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Impact of Fever Prevention in Brain Injured PatientsTerminatedNCT02996266Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Caterpillar™ Arterial Embolization Device Post-Market StudyCompletedNCT04244370Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- GalaFlex Mesh in FaceliftCompletedNCT02053831
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Use of GalaFlex in Ptotic BreastCompletedNCT02081157
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treatment of Native and Synthetic AV FistulaeCompletedNCT02746159
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- FLUENCY® PLUS in the Treatment of Peripheral Artery DiseaseCompletedNCT04765566
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) ArteriesCompletedNCT01870401Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- STARS-R Registry: Retrospective Analysis of Poly-4-hydroxybutyrate (P4HB) Scaffold UseCompletedNCT04195854
Sponsor listed in the registry: C. R. Bard · First submitted after C. R. Bard became part of Becton, Dickinson and Company
- Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent GraftCompletedNCT02649946Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline HerniasCompletedNCT02691962Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- SHERLOCK 3CG™ Diamond Tip Confirmation SystemTerminatedNCT03288766
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval StudyCompletedNCT01394978Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive DiseaseCompletedNCT02655887Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company
- A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.CompletedNCT01961687Not applicable
Sponsor listed in the registry: C. R. Bard · First submitted before C. R. Bard became part of Becton, Dickinson and Company